Intec Pharma (NASDAQ:NTEC) and Affimed (NASDAQ:AFMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.
This table compares Intec Pharma and Affimed’s net margins, return on equity and return on assets.
Insider Institutional Ownership
34.9% of Intec Pharma shares are owned by institutional investors. Comparatively, 41.1% of Affimed shares are owned by institutional investors. 3.3% of Intec Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Intec Pharma and Affimed’s revenue, earnings per share (EPS) and valuation.